NAYA Biosciences, Inc. (NAYA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
5582 Broadcast Court
Sarasota, 34240
United States of America (the)
Phone
N/A
Sector
Healthcare
Industry
Medical - Devices
Employees
30
First IPO Date
November 02, 2020
| Name | Title | Pay | Year Born |
| Steven Shum | Chief Executive Officer & Director | 260,000 | 1971 |
| Andrea Goren | Chief Financial Officer | 215,000 | 1967 |
| Daniel Gedeon Teper | President & Director | 618,141 | 1959 |
| Anna Baran-Djokovic | Senior Vice President of Investor Relations | 0 | N/A |
INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.